검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | polymerase chain reaction |
Overview Company | OSI Pharmaceuticals |
Overview Modality | ANTIBODY |
Overview Target | FRα |
Overview Indication | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) |
Overview Phase | PHASE_2 |
Overview Status | ACTIVE |
MoA Biomarker | Biomarkers for Breast Cancer: A Case-Control Study |
PK/PD Species | Mouse, Consequently |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | Pharmacokinetic |
Toxicology Species | Mouse, Consequently |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | Guggulsterone Alleviates Atherosclerosis in ApoE -/- Mice by Modulating Lipid Metabolism and Inflammatory Responses Associated with Modulation of the Srebp2 / Hmgcr Signaling Axis.. Atherosclerosis (AS) is a chronic inflammatory vascular disease characterized by dysregulated lipid homeostasis and plaque formation. Consequently, there is an ongoing need for therapies with high efficacy and low toxi… |
Clinical Primary efficacy | ORR 3% |
Clinical ORR | 3% |
Clinical Result source | ClinicalTrials.gov NCT01557959 |
Clinical Data Tier / Score | A · 32 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 7월 8일 (6일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | polymerase chain reaction |
Overview Company | OSI Pharmaceuticals |
Overview Modality | ANTIBODY |
Overview Target | FRα |
Overview Indication | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) |
Overview Phase | PHASE_2 |
Overview Status | ACTIVE |
MoA Biomarker | Biomarkers for Breast Cancer: A Case-Control Study |
PK/PD Species | Mouse, Consequently |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | Pharmacokinetic |
Toxicology Species | Mouse, Consequently |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | Guggulsterone Alleviates Atherosclerosis in ApoE -/- Mice by Modulating Lipid Metabolism and Inflammatory Responses Associated with Modulation of the Srebp2 / Hmgcr Signaling Axis.. Atherosclerosis (AS) is a chronic inflammatory vascular disease characterized by dysregulated lipid homeostasis and plaque formation. Consequently, there is an ongoing need for therapies with high efficacy and low toxi… |
Clinical Primary efficacy | ORR 3% |
Clinical ORR | 3% |
Clinical Result source | ClinicalTrials.gov NCT01557959 |
Clinical Data Tier / Score | A · 32 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 7월 8일 (6일 전) |
추천 비교
추천 비교